imatinib mesylate has been researched along with Waldenstrom Macroglobulinemia in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abid, MB; de Mel, S; Ng, SY; Poon, KS; Poon, LM; Wang, S | 1 |
1 other study(ies) available for imatinib mesylate and Waldenstrom Macroglobulinemia
| Article | Year |
|---|---|
Recurrent gastrointestinal bleeding in a patient with IgM paraproteinaemia.
Topics: Antineoplastic Agents; Biopsy; Chemotherapy, Adjuvant; Diagnosis, Differential; Gastrointestinal Hemorrhage; Gastrointestinal Stromal Tumors; Humans; Ileal Diseases; Imatinib Mesylate; Immunoglobulin M; Lymph Nodes; Male; Middle Aged; Paraproteinemias; Proto-Oncogene Proteins c-kit; Recurrence; Treatment Outcome; Waldenstrom Macroglobulinemia | 2018 |